Nautilus Biotechnology (NAUT) FY Conference Transcript

Nautilus Biotechnology (NAUT) FY Conference June 10, 2025 02:00 PM ET Speaker0 You do, okay. Speaker1 question, I'll answer that. Speaker0 Oh, you're right. It does have that. Great. Good afternoon, everyone. I'm Matt Sykes, Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure of welcoming Anna Mari from Nautilus Biotechnologies. Thank you, Anna, for being here. Appreciate it. Maybe just starting off with big picture, can you give us kind of a brief overview of the proteomics mar ...